Clinical trial
7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With…
NCT00098956 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00098956 |
|---|---|
| Title | 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer |
| Official title | A Phase II Study of UCN-01 in Combination With Topotecan in Patients With SCLC Who Relapsed or Progressed >= 3 Months After Completing First-Line Platinum-Based Chemotherapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride, 7-hydroxystaurosporine |
| Enrollment | 19 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Dec 9, 2004 |
| Last update posted | Jul 23, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: